Contact

News

Stock Info

Governance

Financials & Filings

Resources

Stock

Stock info

Investors Overview

GE HealthCare is a leading global healthcare solutions provider of advanced medical technology, pharmaceutical diagnostics, and AI, cloud and software solutions that help clinicians tackle the world’s most complex diseases. Serving patients and providers for 130 years, GE HealthCare is delivering bold innovations designed for the next era of medicine across its Advanced Imaging Solutions, Pharmaceutical Diagnostics, and Patient Care Solutions segments to help clinicians deliver more personalized, precise patient care. We are a $20.6 billion business with approximately 54,000 colleagues working to create a world where healthcare has no limits.

Show all

GE HealthCare Second Quarter 2026 Earnings Conference Call

Earnings Webcast

Earnings Release 933.5 KB

Earnings Presentation 740.8 KB

Earnings Supplemental 103.1 KB

Hear from CEO Peter Arduini

View all events

Presentations

44th Annual J.P. Morgan Healthcare Conference – January 13, 2026

GE HealthCare Investor Day – November 21, 2024

GE HealthCare’s 2025 Sustainability Report

>$1.7bn

innovation investment*

1bn

patients served annually

~5m

units installed across the globe

$20.6bn

revenue in 2025

*Includes Research and development expense plus engineering costs for design follow-through on new product introductions and key product lifecycle maintenance subsequent to the initial product launch reported within cost of revenues

News & events

Stay up to date with GE HealthCare's latest investor news and events

News
Latest events

August 4, 2026

GE HealthCare expands the LOGIQ e ultrasound platform with new LOGIQ e family

News Release

August 3, 2026

GE HealthCare expands breast imaging portfolio with Invenia ABUS Prime and launch of ABUS StreamVue

News Release

July 29, 2026

GE HealthCare reports second quarter 2026 financial results

News Release

July 29, 2026 at 8:30 AM EDT

GE HealthCare Second Quarter 2026 Earnings Conference Call

June 3, 2026 at 9:20 AM EDT

Jefferies Global Healthcare Conference

May 12, 2026 at 10:40 AM PDT

Bank of America’s 2026 Health Care Conference

More information is coming soon.

A message from Chief Commercial and Growth Officer, Global Markets

As demand for radiopharmaceuticals continues to grow, we are seeing strong momentum across our portfolio, including our disease-specific tracer that support greater diagnostic confidence. Catholic Health is one example of a health system we’re collaborating with to advance precision care, beginning with its early adoption of Flyrcado and expanding through a recent Care Alliance that includes investments in PET/CT and nuclear medicine capabilities. Together, these efforts reflect the growing demand for precision diagnostics and advanced technologies that help bring innovative care closer to patients.”
Catherine Estrampes, Chief Commercial and Growth Officer, Global Markets, GE HealthCare